• Most Popular
  • Most Shared

Health Videos

Leeches therapy industry booms

As leech therapy gains popularity, a laboratory near Moscow is boosting production of this increasingly valuable -- and slimy -- commodity.  Video 

Under the knife, without the knife

Autopsies have gone virtual thanks to Swiss forensic pathologists who are conducting about 100 ''virtopsies'' a year.  Video 

First days after HIV infection may hold vaccine key

GENEVA
Mon Dec 1, 2008 4:15pm EST
Phanice Nyandoya (L), 2, and Antony Ochien (R), 4, both living with HIV/AIDS listen to their class teacher at the Dagoretti Children's Centre in Nairobi November 28, 2008. An estimated 33 million people worldwide were living with the HIV virus, mostly in sub-Saharan Africa, at the end of 2007. AIDS has killed 25 million since being identified in 1981. REUTERS/Antony Njuguna

GENEVA (Reuters) - The body's initial response to contracting HIV could provide the answers scientists need to develop a vaccine for the AIDS-causing virus, a Nobel-winning expert said on Monday.

Science  |  Health

The AIDS epidemic has killed about 25 million people, and about 33 million worldwide are now infected with HIV. Cocktails of drugs can control the virus but so far there is no cure.

Francoise Barre-Sinoussi, who shared the 2008 Nobel prize for medicine with Luc Montagnier for their discovery of HIV a quarter-century ago, told a World AIDS Day event that the human body reacts very distinctly -- and quickly -- to HIV infection.

The nearly immediate cellular responses seen in the gut and elsewhere could point scientists toward a vaccine that keeps HIV from taking hold and morphing into the immunity-destroying disease, the French expert said.

"Everything is decided very early after exposure to the virus ... When I say very early after, it is a matter of days," she said in a speech at the World Health Organization.

"If we know better the early events of the acute infection, we can think about developing a better vaccine strategy," she said, warning: "If we don't make progress in this basic knowledge, we will never have a vaccine."

Recent efforts to develop a vaccine by jump-starting immune-system cells that tackle the virus -- such as one last year by Merck -- have yielded disappointing results.

Barre-Sinoussi said such "conventional" vaccines would not be enough to tackle HIV, which is a retrovirus, meaning it copies bits of its own genetic code into the DNA of its host.

"We have to consider the conventional approach together with another approach that considers the pathogenic signals," she said. "We need to understand better the role of genetics."

The Institut Pasteur expert also called for more research into co-infections between HIV and tuberculosis, and hit back at those who say the billions of dollars that have been funneled into AIDS projects have drained funds needed for other diseases.

"I am a little bit surprised to see an opposition between the fight against HIV and other primary health issues. It is a total misunderstanding and a major mistake," she said. "I do not understand why these people cannot work together."

(Editing by Katie Nguyen)



More from Reuters

Photo

AIG executive resigns over pay limits

NEW YORK (Reuters) - A top executive at American International Group Inc has resigned because of pay curbs imposed by the Obama Administration's pay czar, the insurer said on Wednesday.

A security camera sits on a building in New York City March 6, 2008. REUTERS/Joshua Lott

Trial run in Times Square

Critics say the Sept. 11 trials will endanger America's most populated city. Will a $75-million New Year's Eve plan hold up as New York's security template?  Full Article 

People walk past a branch of Bank of America in New York's financial district April 28, 2009. REUTERS/Brendan McDermid

Move your money

Boycotting "too big to fail" banks is a great idea -- so long as investors remember that banks aren't the only ones responsible for the crisis.  Full Article